Dr. John Cush RheumNow
5 years 5 months ago
RheumNow Podcast is Up! – with news of Uppers and Downers. Read about Vaccine success, CKD gout prophylaxis, TOFA in AS & too much IL-17 inhib can be a problem https://t.co/kt63YrQ0Sw Listen iTunes> https://t.co/FHJv01AAbC or Android SoundCloud>>https://t.co/IyYvjkWUc1
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.
Dr. John Cush RheumNow
5 years 5 months ago
Metanalysis of 9 studies, and 1132 lupus pregnancies shows that hydroxychloroquine treatment significantly reduced the risk of preeclampsia (OR 0.35), pregnancy hypertension (OR0.41)and prematurity (OR 0.55), but no effect on rates of HELLP, DM, Ab https://t.co/P9MXjDpuiO
Dr. John Cush RheumNow
5 years 5 months ago
News Feature: Golimumab Effective in non-radiographic Axial Spondyloarthritis
https://t.co/KWqQLHWIiB
The ACR COVID-19 Vaccine Clinical Guidance was originally published on February 8, 2021 and updated on March 4, 2021. On April 28, 2021, new recommendations were added regarding mycophenolate, methotrexate, acetaminophen, and NSAID timing considerations,
A metanalysis showed that while adverse events (AEs) are common when methotrexate is used in rheumatoid arthritis or inflammatory arthritis patients, serious AEs ranged from 2.1 to 9.5% and drug discontinuations ranged from 6.7% to 15.5%, mostly due to gastrointestinal events.
A large patient cohort study suggests that the mean diagnostic delay (DD) in European axial spondyloarthritis (axSpA) patients is 7.4 years, moreso in women and younger patients.
An online survey of 2,652 patients from 13 countries (European Map of Axial Spondyloarthritis - EMAS) asked patients about their onset of symptoms and the time it took ot diagnose axSpA) and found that the average DD was 7.4 ± 8.4 years.
Dr. John Cush RheumNow
5 years 5 months ago
Check out this issue of Arthritis & Rheumatism from 1961. In addition to the great article by Charles Ragan on the "History of Rheumatoid Factor" (pg 571), thumb thru the pages to see the Ads and what rheumatology looked like 60 years ago. https://t.co/Ed9watO3Dw
Dr. John Cush RheumNow
5 years 5 months ago
CDC study shows that adults >65yrs who are fully vaccinated (w/ Pfizer or Moderna) showed 94% drop in COVID-19 hospitalization (64for among partially vaccinated adults) https://t.co/iJrbiNJg2r
Dr. John Cush RheumNow
5 years 5 months ago
Will you be attending our Tuesday Night Rheumatology series? Events and topics linked below.
Sign up today!
https://t.co/ugGaPvBsLD
Dr. John Cush RheumNow
5 years 5 months ago
Gout Prophylaxis in patients with severe CKD? Metanalysis of 33 studies suggests 1) lack of good data guidance; 3) Colchicind is associated w/ toxicity w/ CKD (neuromyopathy, rhabdomyolysis; 3) anakinra - works, expensive, little/no toxicity https://t.co/VhI0wRC0VO
Dr. John Cush RheumNow
5 years 5 months ago
News Feature: Search Tofacitinib in Ankylosing Spondylitis
https://t.co/cTRvB3cvsh
A phase III trial assessing the efficacy and safety of tofacitinib in adults with with active ankylosing spondylitis (AS) shows that JAK inhibitiion was superior to placebo in a 48 week study.
